World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
65
Citations
27839
World Ranking
1641
National Ranking
49

Eric Delabesse publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Eric Delabesse sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 236 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Eric Delabesse D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Eric Delabesse sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 65 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Eric Delabesse is affiliated with the Federal University of Toulouse Midi-Pyrénées in France. Their research primarily falls within the field of Medicine, with a particular focus on Hematology, Genetics, and Molecular Biology. Additional areas of study in their work include Public Health, Environmental and Occupational Health, and Immunology.

The main topics of Eric Delabesse's research encompass:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research
  • Multiple Myeloma Research and Treatments
  • Chronic Lymphocytic Leukemia Research

Eric Delabesse's publications have appeared most frequently in the following venues:

  • Blood
  • Blood Advances
  • Leukemia
  • Blood Cancer Journal
  • HemaSphere

Recent notable papers include:

  • "The KMT2A recombinome of acute leukemias in 2023" (2023), published in Leukemia
  • "Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study" (2022), published in Blood
  • "Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patients" (2020), published in American Journal of Hematology
  • "Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries" (2021), published in Leukemia
  • "VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy" (2021), published by Lara D. Veeken

Eric Delabesse has collaborated frequently with several coauthors in their research work, including:

  • Christian Récher
  • Sarah Bertoli
  • Arnaud Pigneux
  • Laëtitia Largeaud
  • Audrey Bidet

Best Publications

  • LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

    S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

    Salima Hacein-Bey-Abina;Alexandrine Garrigue;Gary P. Wang;Jean Soulier

  • Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

    van Dongen Jj;Macintyre Ea;Gabert Ja;Delabesse E

  • Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program

    E Beillard;N Pallisgaard;V H J van der Velden;W Bi

  • Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma

    Christophe Cellier;Eric Delabesse;Christine Helmer;Natacha Patey

  • The MLL recombinome of acute leukemias in 2017

    C Meyer;T Burmeister;D Gröger;G Tsaur

  • Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study

    Françoise Huguet;Thibaut Leguay;Emmanuel Raffoux;Xavier Thomas

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia - Results of the GRAAPH-2003 study

    Adrienne de Labarthe;Philippe Rousselot;Francoise Huguet-Rigal;Eric Delabesse

  • Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

    Jean-Emmanuel Sarry;Kathleen Murphy;Robin Perry;Patricia V. Sanchez

  • Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party

    D. Grimwade;A. Biondi;M.J. Mozziconacci;A. Hagemeijer

  • Abnormal Intestinal Intraepithelial Lymphocytes in Refractory Sprue

    Christophe Cellier;Natacha Patey;Laurent Mauvieux;Bana Jabri

  • Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

    Eric Jourdan;Nicolas Boissel;Sylvie Chevret;Eric Delabesse

  • Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

    Kheira Beldjord;Sylvie Chevret;Vahid Asnafi;Françoise Huguet

  • TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

    Olivier Kosmider;Véronique Gelsi-Boyer;Meyling Cheok;Sophie Grabar

  • A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)

    Konstantinos J Mavrakis;Joni Van der Meulen;Andrew L Wolfe;Andrew L Wolfe;Xiaoping Liu

  • Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy

    Annette Deichmann;Salima Hacein-Bey-Abina;Manfred Schmidt;Manfred Schmidt;Alexandrine Garrigue

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

Frequent Co-Authors

Christian Recher
Christian Recher Federal University of Toulouse Midi-Pyrénées
Elizabeth Macintyre
Elizabeth Macintyre Necker-Enfants Malades Hospital
Claude Preudhomme
Claude Preudhomme University of Lille
Hervé Dombret
Hervé Dombret Université Paris Cité
Norbert Ifrah
Norbert Ifrah Grenoble Alpes University
Olivier Bernard
Olivier Bernard University of Paris-Saclay
Hélène Cavé
Hélène Cavé Université Paris Cité
Franki Speleman
Franki Speleman Ghent University
Frederic Davi
Frederic Davi Assistance Publique – Hôpitaux de Paris

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Molecular Biology opens doors to a wide range of specialized allied health and nursing pathways. Online degree programs offer flexibility and speed, making them a popular choice for advancing your education and enhancing career prospects.

For those in nursing, the rn to bsn in 6 months option can help registered nurses achieve a Bachelor of Science in Nursing quickly. This is ideal for professionals wanting to fast-track their credentials while balancing work or family commitments.

If you hold an associate degree in nursing, bridging to advanced roles is possible through adn to np programs. These pathways allow nurses to become nurse practitioners in a condensed timeframe.

Those without a nursing background can enter the profession through direct entry msn programs online. These intensive options are designed for career-changers holding a non-nursing bachelor’s degree.

When comparing online programs, consider factors like accreditation, cost, and flexibility. For an in-depth look at leading universities, see this comparison of wgu vs chamberlain to make an informed decision about your educational journey.

Best Scientists Citing Eric Delabesse

Trending Scientists

Recently Published Articles